Search

Your search keyword '"Pfizer Inc. -- Reports"' showing total 1,497 results
Start Over Descriptor "Pfizer Inc. -- Reports" Topic business
1,497 results on '"Pfizer Inc. -- Reports"'

1. 2023 Pipeline Report

Author

Broderick, Jason M.

Subjects
United States. Food and Drug Administration -- Reports, Pfizer Inc. -- Reports, Boston Scientific Corp. -- Reports, Prostate cancer -- Reports, Medical test kit industry -- Reports, Metastasis -- Reports, Sensors -- Reports, Medical equipment and supplies industry -- Reports, Kidney stones -- Reports, Pharmaceutical industry -- Reports, Business, Health care industry
Abstract

FEBRUARY LithoVue Elite system for ureteroscopy The FDA granted 510(k) clearance to the LithoVue Elite Single-Use Digital Flexible Ureteroscope System. (1) The device is the first of its kind, with [...]

Published
2023

2. Heart Failure Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

Subjects
Pfizer Inc. -- Reports, Bristol-Myers Squibb Co. -- Reports, Business -- Research, Pharmaceutical industry -- Reports, Heart failure -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-October 23, 2024-: Heart Failure Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers (C)1994-2024 M2 COMMUNICATIONS RDATE:22102024 DelveInsight's, 'Heart Failure Pipeline Insight 2024' report provides comprehensive [...]

Published
2024

3. Metastatic Castration-Sensitive Prostate Cancer Clinical Trial Pipeline Insights Featuring 35+ Companies | DelveInsight

Subjects
Bayer AG -- Reports, Pfizer Inc. -- Reports, Regeneron Pharmaceuticals Inc. -- Reports, Eli Lilly and Co. -- Reports, Business -- Research, Prostate cancer -- Reports, Metastasis -- Reports, Clinical trials -- Reports, Testosterone -- Reports, Pharmaceutical industry -- Reports, Business, News, opinion and commentary
Abstract

Metastatic castration-sensitive prostate cancer (mCSPC), also known as metastatic hormone-sensitive prostate cancer (mHSPC), refers to prostate cancer that has spread beyond the prostate but still responds to therapies that lower [...]

Published
2024

4. Metastatic Colorectal Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

Subjects
Pfizer Inc. -- Reports, Business -- Research, Metastasis -- Reports, Antineoplastic agents -- Reports, Colorectal cancer -- Reports, Trifluridine -- Reports, Pharmaceutical industry -- Reports, Antimitotic agents -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-October 15, 2024-: Metastatic Colorectal Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers (C)1994-2024 M2 COMMUNICATIONS RDATE:14102024 DelveInsight's, 'Metastatic Colorectal Cancer Pipeline Insight, 2024' report [...]

Published
2024

5. New COVID-19 Study Findings Have Been Reported from University of Ottawa (Short- and Long-term Outcomes of Cardiac Adverse Events Following Covid-19 Immunization Managed In a Canadian Pediatric Center)

Subjects
Pfizer Inc. -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Immunization -- Research -- Reports, Pediatric cardiology -- Reports -- Research, Children -- Health aspects, Vaccines -- Complications and side effects -- Research, Cardiac patients -- Research -- Reports, Coronaviruses -- Research -- Reports, Pharmaceutical industry -- Reports -- Research, Business, Health, Health care industry, University of Ottawa -- Reports
Abstract

2024 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Investigators publish new report on Coronavirus - COVID-19. According to [...]

Published
2024

6. New Cancer Study Findings Have Been Reported by Researchers at Pfizer (Identifying and Addressing the Needs of Caregivers of Patients With Cancer: Evidence On Interventions and the Role of Patient Advocacy Groups)

Subjects
Pfizer Inc. -- Reports, Oncology, Experimental -- Reports, Cancer patients -- Reports -- Research, Cancer -- Reports -- Research, Patient advocacy -- Research -- Reports, Caregivers -- Research -- Reports, Pharmaceutical industry -- Reports -- Research, Business, Health, Health care industry
Abstract

2024 OCT 29 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Cancer is now available. According to news reporting from Cypress, Texas, [...]

Published
2024

7. Pfizer Inc. Files SEC Form 8-K, Current Report: (Oct. 15, 2024)

Subjects
United States. Securities and Exchange Commission -- Reports, Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 OCT 28 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities [...]

Published
2024

8. New Findings from Cedars-Sinai Medical Center Describe Advances in Veterans Health (Real-world Outcomes Following Biochemical Recurrence After Definitive Therapy With a Short Prostate-specific Antigen Doubling Time: Potential Role of Early ...)

Subjects
United States. Veterans Health Administration -- Reports -- Evaluation, Pfizer Inc. -- Reports, Medical centers -- Reports -- Research, Prostate cancer -- Research -- Care and treatment, Hospitals, Veterans' -- Reports -- Research, Antigens -- Reports -- Research, Veterans -- Reports -- Research, Pharmaceutical industry -- Reports -- Research, Business, Health, Health care industry, Cedars-Sinai Medical Center -- Evaluation -- Reports
Abstract

2024 OCT 8 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Veterans Health. According to news reporting originating in Los Angeles, [...]

Published
2024

9. Findings from Dana-Farber Cancer Institute Provide New Insights into Prostate Cancer (Tailoring Language for Genitourinary Function In Patients With Newly Diagnosed Prostate Cancer To Facilitate Discussions In Diverse Populations and Overcome ...)

Subjects
Pfizer Inc. -- Reports, Prostate cancer -- Care and treatment, Cancer patients -- Care and treatment, Literacy -- Massachusetts -- United States, Pharmaceutical industry -- Reports, Business, Health, Health care industry
Abstract

2024 OCT 8 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New research on Oncology - Prostate Cancer is the subject of a report. According to [...]

Published
2024

10. New Business Study Findings Reported from Pfizer Inc. [In-Clinic and Natural Gait Observations master protocol (I-CAN-GO) to validate gait using a lumbar accelerometer]

Subjects
Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports -- Research, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- New study results on business have been published. According to news reporting originating from [...]

Published
2024

11. New COVID-19 Study Findings Have Been Reported from Harvard University T.H. Chan School of Public Health (Interventions to Reduce COVID-19 Vaccine Hesitancy among Black and African American Individuals in the United States: A Systematic ...)

Subjects
Pfizer Inc. -- Reports, Vaccination -- Reports, Vaccines -- Reports, Pharmaceutical industry -- Reports, African Americans -- Reports, Business, Health, Health care industry
Abstract

2024 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- New research on COVID-19 is the subject of a new [...]

Published
2024

12. Findings from Riyadh in COVID-19 Reported (The Impact of COVID-19 Vaccination Side-Effects on Work Attendance among Saudi Healthcare Workers)

Subjects
Pfizer Inc. -- Reports, AstraZeneca PLC -- Reports, Vaccination -- Research -- Surveys -- Reports, Workers -- Surveys, RNA -- Research -- Surveys -- Reports, Medical personnel -- Surveys, Coronaviruses -- Surveys -- Research -- Reports, Pharmaceutical industry -- Reports -- Surveys -- Research, Business, Health, Health care industry
Abstract

2024 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- New research on COVID-19 is the subject of a new [...]

Published
2024

13. Research on Toxicology Detailed by Researchers at Pfizer (The effect of iron status on gadolinium deposition in the rat brain: mechanistic implications)

Subjects
Pfizer Inc. -- Reports, Brain -- Reports, Gadolinium -- Reports, Pharmaceutical industry -- Reports, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 SEP 9 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Research findings on toxicology are discussed in a new report. According to news reporting [...]

Published
2024

14. New Data from Pfizer Worldwide Research and Development Illuminate Findings in Pharmaceuticals (Early-stage Flow Process Development of a Key Intermediate Toward Pf-07265807, an Axl-mer Inhibitor Oncology Candidate)

Subjects
Pfizer Inc. -- Reports, Solvent wastes -- Reports, Industrial research -- Connecticut -- United States, Pharmaceutical industry -- Reports, Research and development, Business, Health
Abstract

2024 SEP 1 (NewsRx) -- By a News Reporter-Staff News Editor at Oncology Business Week -- A new study on Pharmaceuticals is now available. According to news reporting originating from [...]

Published
2024

16. Obesity Pipeline Drugs 2024 | Zealand Pharma, Sciwind Biosciences, Genexine, Sirnaomics, Sparrow Pharmaceuticals, Shionogi, Regor Pharmaceuticals, Innovent Biologics, Pfizer, NodThera Limited, Boehrin

Subjects
Pfizer Inc. -- Reports, Boehringer Ingelheim GmbH -- Reports, Palatin Technologies Inc. -- Reports, Biological products industry -- Reports, Business -- Research, Obesity -- Drug therapy, Drugs -- Reports, Type 2 diabetes -- Drug therapy, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-August 27, 2024-: Obesity Pipeline Drugs 2024 | Zealand Pharma, Sciwind Biosciences, Genexine, Sirnaomics, Sparrow Pharmaceuticals, Shionogi, Regor Pharmaceuticals, Innovent Biologics, Pfizer, NodThera Limited, Boehrin (C)1994-2024 M2 COMMUNICATIONS RDATE:26082024 [...]

Published
2024

17. Esophageal Cancer Pipeline Drugs 2024 | BeiGene, AstraZeneca, CSPC ZhongQi Pharmaceutical Technology, Amgen, Jiangsu Hengrui Medicine, Oncolys Biopharma, Pfizer, Novartis

Subjects
Merck KGaA -- Reports, Pfizer Inc. -- Reports, Novartis AG -- Reports, AstraZeneca PLC -- Reports, Biological products industry -- Reports, Business -- Research, Pertuzumab -- Reports, Panitumumab -- Reports, Pharmaceutical industry -- Reports, Esophageal cancer -- Drug therapy, Business, Business, international
Abstract

M2 PRESSWIRE-August 12, 2024-: Esophageal Cancer Pipeline Drugs 2024 | BeiGene, AstraZeneca, CSPC ZhongQi Pharmaceutical Technology, Amgen, Jiangsu Hengrui Medicine, Oncolys Biopharma, Pfizer, Novartis (C)1994-2024 M2 COMMUNICATIONS RDATE:12082024 DelveInsight, 'Esophageal [...]

Published
2024

18. Esophageal Cancer Pipeline 2024 | BeiGene, AstraZeneca, CSPC ZhongQi Pharmaceutical Technology, Amgen, Jiangsu Hengrui Medicine, Oncolys Biopharma, Pfizer, Novartis, Luye Pharma, Eli Lilly and Company

Subjects
Pfizer Inc. -- Reports, Novartis AG -- Reports, AstraZeneca PLC -- Reports, Eli Lilly and Co. -- Reports, Biological products industry -- Reports, Pertuzumab -- Reports, Panitumumab -- Reports, Pharmaceutical industry -- Reports, Esophageal cancer -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-July 9, 2024-: Esophageal Cancer Pipeline 2024 | BeiGene, AstraZeneca, CSPC ZhongQi Pharmaceutical Technology, Amgen, Jiangsu Hengrui Medicine, Oncolys Biopharma, Pfizer, Novartis, Luye Pharma, Eli Lilly and Company (C)1994-2024 [...]

Published
2024

19. Follicular Lymphoma Pipeline 2024 | Mab Works, AstraZeneca, ADC Therapeutics, Xynomic Pharmaceuticals, AbbVie, Nurix, InnoCare Pharma, LTZ Therapeutics, Hutchmed, Regeneron, Pfizer

Subjects
Pfizer Inc. -- Reports, AstraZeneca PLC -- Reports, Lymphomas -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-July 9, 2024-: Follicular Lymphoma Pipeline 2024 | Mab Works, AstraZeneca, ADC Therapeutics, Xynomic Pharmaceuticals, AbbVie, Nurix, InnoCare Pharma, LTZ Therapeutics, Hutchmed, Regeneron, Pfizer (C)1994-2024 M2 COMMUNICATIONS RDATE:08072024 DelveInsight's, [...]

Published
2024

20. Renal Cell Carcinoma Pipeline 2024 | AstraZeneca, Infinity Pharmaceuticals, Ipsen, Novartis, Aveao pharmaceuticals, Merck Sharp & Dohme Corp., Pfizer, Bayer Healthcare, Incyte Corporation, GSK

Subjects
Infinity Pharmaceuticals -- Reports, Pfizer Inc. -- Reports, Novartis AG -- Reports, Bayer HealthCare AG -- Reports, Incyte Corp. -- Reports, Merck Sharp & Dohme Corp. -- Reports, AstraZeneca PLC -- Reports, Biological products industry -- Reports, Antineoplastic agents -- Reports, Biotechnology industry -- Reports, Health care industry -- Reports, Drugs -- Reports, Carcinoma, Renal cell -- Reports, Pharmaceutical industry -- Reports, Antimitotic agents -- Reports, Health care industry, Business, Business, international
Abstract

M2 PRESSWIRE-July 9, 2024-: Renal Cell Carcinoma Pipeline 2024 | AstraZeneca, Infinity Pharmaceuticals, Ipsen, Novartis, Aveao pharmaceuticals, Merck Sharp & Dohme Corp., Pfizer, Bayer Healthcare, Incyte Corporation, GSK (C)1994-2024 M2 [...]

Published
2024

21. Acute Pancreatitis Pipeline Analysis 2024: FDA Approvals and Emerging Therapies by DelveInsight | Dynavax Tech, Fresenius SE, GlaxoSmithKline, Abbott, B. Braun SE, Baxter

Subjects
Pfizer Inc. -- Reports, Dynavax Technologies Corp. -- Reports, Fresenius SE & Company KGaA -- Reports, Medical test kit industry -- Reports, Medical equipment and supplies industry -- Reports, Pancreatitis -- Reports, Drug approval -- Reports, Clinical trials -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-June 28, 2024-: Acute Pancreatitis Pipeline Analysis 2024: FDA Approvals and Emerging Therapies by DelveInsight | Dynavax Tech, Fresenius SE, GlaxoSmithKline, Abbott, B. Braun SE, Baxter (C)1994-2024 M2 COMMUNICATIONS [...]

Published
2024

22. The Corporate Reputation of Canadian Pharma, 2023-2024 - 100 Patient Groups Present their Views - Access to New Medicines Chief Among the Difficulties Experienced, due to Regulatory Delays - ResearchAndMarkets.com

Subjects
Pfizer Inc. -- Reports, Boehringer Ingelheim GmbH -- Reports, AstraZeneca PLC -- Reports, Cancer patients -- Surveys, Drugs -- Surveys -- Reports, Pharmaceutical industry -- Reports -- Surveys, Business, Business, international
Abstract

DUBLIN -- 'The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups' report has been added to ResearchAndMarkets.com's [...]

Published
2024

23. The Corporate Reputation of Canadian Pharma, 2023-2024 - 100 Patient Groups Present their Views - Access to New Medicines Chief Among the Difficulties Experienced, due to Regulatory Delays

Subjects
Pfizer Inc. -- Reports, Boehringer Ingelheim GmbH -- Reports, AstraZeneca PLC -- Reports, Drugs -- Surveys -- Reports, Pharmaceutical industry -- Reports -- Surveys, Business, Business, international
Abstract

M2 PRESSWIRE-June 26, 2024-: The Corporate Reputation of Canadian Pharma, 2023-2024 - 100 Patient Groups Present their Views - Access to New Medicines Chief Among the Difficulties Experienced, due to [...]

Published
2024

24. Researchers plot migraine-menstruation connection

Subjects
Pfizer Inc. -- Reports, Migraine -- Reports -- Surveys -- Health aspects, Menstruation -- Reports -- Surveys -- Health aspects, Pharmaceutical industry -- Reports -- Health aspects -- Surveys, Business, Computers and office automation industries, Telecommunications industry
Abstract

Byline: Hannah Docter-Loeb About 31 percent of women who reported migraines in a national health survey said they experienced them during menstruation, according to an analysis by researchers at Georgetown [...]

Published
2024

25. Pfizer price target lowered to $34 from $35 at Barclays

Subjects
Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports, Business, News, opinion and commentary
Abstract

Barclays lowered the firm's price target on Pfizer to $34 from $35 and keeps an Equal Weight rating on the shares spot the Q3 report. The analyst says the Street's [...]

Published
2023

26. Pfizer price target lowered to $36 from $39 at JPMorgan

Subjects
Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports, Business, News, opinion and commentary
Abstract

JPMorgan lowered the firm's price target on Pfizer to $36 from $39 and keeps a Neutral rating on the shares ahead of the Q3 report. The firm is below Street [...]

Published
2023

27. New Clinical Pharmacology and Therapeutics Findings Has Been Reported by Investigators at Bristol-Myers Squibb Company (Clinical Implications of Co-administering Apixaban With Key Interacting Medications)

Subjects
Pfizer Inc. -- Reports, Bristol-Myers Squibb Co. -- Reports, Pharmacology -- Reports, Drugs -- Reports, Apixaban -- Reports, Pharmaceutical industry -- Reports, Business, Health, Health care industry
Abstract

2024 AUG 25 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Investigators publish new report on Drugs and Therapies - Clinical [...]

Published
2024

28. Studies from Pfizer Worldwide Research Yield New Data on COVID-19 (In Vitro Selection and Analysis of Sars-cov-2 Nirmatrelvir Resistance Mutations Contributing To Clinical Virus Resistance Surveillance)

Subjects
Pfizer Inc. -- Reports, Antiviral agents -- Research, Drug resistance -- Research -- Genetic aspects, Severe acute respiratory syndrome -- Research -- Genetic aspects, Coronaviruses -- Health aspects -- Research -- Reports -- Genetic aspects, Pharmaceutical industry -- Reports -- Health aspects -- Research, Business, Pharmaceuticals and cosmetics industries, Health, Paxlovid (Medication) -- Reports -- Research -- Health aspects
Abstract

2024 AUG 19 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Research findings on Coronavirus - COVID-19 are discussed in a new report. According to [...]

Published
2024

29. Pfizer Inc. Files SEC Form 8-K, Current Report: (Jul. 26, 2024)

Subjects
United States. Securities and Exchange Commission -- Reports, Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 AUG 12 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities [...]

Published
2024

30. Recent Findings from School of Information Engineering Provides New Insights into COVID-19 (Comparing the Accuracy of Ann With Transformer Models for Sentiment Analysis of Tweets Related To Covid-19 Pfizer Vaccines)

Subjects
Pfizer Inc. -- Reports, Vaccination -- Research -- Reports, Electric transformers -- Reports -- Research, Natural language interfaces -- Research -- Reports, Computational linguistics -- Research -- Reports, Language processing -- Research -- Reports, Vaccines -- Research, Coronaviruses -- Research -- Reports, Pharmaceutical industry -- Reports -- Research, Business, Health, Health care industry, Research, Reports
Abstract

2024 AUG 11 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- New research on Coronavirus - COVID-19 is the subject of [...]

Published
2024

31. New Findings from University of Bristol Describe Advances in COVID-19 (Effectiveness of Mrna Covid-19 Vaccines As First Booster Doses In England: an Observational Study In Opensafely-tpp)

Subjects
Pfizer Inc. -- Reports, Messenger RNA -- Reports, Vaccines -- Reports, Coronaviruses -- Reports, Pharmaceutical industry -- Reports, Business, Health, Health care industry, University of Bristol -- Reports, Comirnaty (Vaccine) -- Reports
Abstract

2024 AUG 4 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Fresh data on Coronavirus - COVID-19 are presented in a [...]

Published
2024

32. Studies from University of Health Sciences Turkey Further Understanding of COVID-19 (Impact of Pfizer-BioNTech COVID-19 Vaccination on the Menstrual Cycle)

Subjects
Pfizer Inc. -- Reports, Vaccination -- Research -- Surveys -- Reports, Menstruation -- Reports -- Research -- Surveys, Coronaviruses -- Surveys -- Research -- Reports, Pharmaceutical industry -- Reports -- Research -- Surveys, Business, Health, Health care industry
Abstract

2024 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Fresh data on COVID-19 are presented in a new report. [...]

Published
2024

33. Pfizer Inc. Files SEC Form 8-K, Current Report: (Jul. 10, 2024)

Subjects
United States. Securities and Exchange Commission -- Reports, Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 JUL 22 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities [...]

Published
2024

34. Pfizer Inc. Files SEC Form 8-K, Current Report: (Jul. 1, 2024)

Subjects
United States. Securities and Exchange Commission -- Reports, Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 JUL 15 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities [...]

Published
2024

35. Data on COVID-19 Detailed by Researchers at Emory University School of Medicine (Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case-Control Study)

Subjects
Pfizer Inc. -- Reports, Vaccines -- Research, Pharmaceutical industry -- Reports -- Research, Business, Health, Health care industry, Emory University. School of Medicine -- Reports, Comirnaty (Vaccine) -- Reports -- Research
Abstract

2024 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- New study results on COVID-19 have been published. According to [...]

Published
2024

36. Pfizer Details Findings in COVID-19 (Self-assembly Properties of an Amphiphilic Phosphate Ester Prodrug Designed for the Treatment of Covid-19)

Subjects
Pfizer Inc. -- Reports, Phosphates -- Reports -- Research, Coronaviruses -- Research -- Reports, Pharmaceutical industry -- Reports -- Research, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 JUL 8 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- A new study on Coronavirus - COVID-19 is now available. According to news originating [...]

Published
2024

37. Study Findings from Pfizer Inc. Provide New Insights into Data Processing (High-throughput Compound Quality Assessment With High-mass-resolution Acoustic Ejection Mass Spectrometry: an Automatic Data Processing Toolkit)

Subjects
Pfizer Inc. -- Reports, Electronic data processing -- Research -- Reports, Mass spectrometry -- Reports -- Research, Pharmaceutical industry -- Reports -- Research, Quality control -- Research -- Reports, Quality control, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Investigators discuss new findings in Information Technology - Data Processing. According to news reporting [...]

Published
2024

38. Pfizer Inc. Files SEC Form SD, Specialized Disclosure Report: (May 31, 2024)

Subjects
United States. Securities and Exchange Commission -- Reports, Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities [...]

Published
2024

39. Findings from Pfizer Research and Development Provide New Insights into COVID-19 (Flow-nmr As a Process-monitoring Tool for Mrna Ivt Reaction)

Subjects
Pfizer Inc. -- Reports, Nuclear magnetic resonance -- Reports, Messenger RNA -- Reports, Vaccines -- Reports, Industrial research -- Connecticut -- United States, Coronaviruses -- Reports, Pharmaceutical industry -- Reports, Virus diseases -- Reports, Research and development, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Research findings on Coronavirus - COVID-19 are discussed in a new report. According to [...]

Published
2024

40. Researchers from Alagappa University Detail Research in COVID-19 (Novel scaffolds identification against Mpro of SARS-CoV-2 using shape based screening and molecular simulation methods)

Subjects
Pfizer Inc. -- Reports, Simulation methods -- Analysis -- Reports -- Methods, Pharmaceutical industry -- Reports -- Methods -- Analysis, Business, Health, Health care industry
Abstract

2024 JUN 16 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Fresh data on COVID-19 are presented in a new report. [...]

Published
2024

41. Findings in Cancer Reported from Pfizer (Histone Lysine Acetyltransferase Inhibitors: an Emerging Class of Drugs for Cancer Therapy)

Subjects
Pfizer Inc. -- Reports, Lysine -- Research -- Reports -- Health aspects, Antineoplastic agents -- Research, Cancer -- Drug therapy, Epigenetic inheritance -- Reports -- Health aspects -- Research, Pharmaceutical industry -- Reports -- Health aspects -- Research, Antimitotic agents -- Research, Business, Health, Health care industry
Abstract

2024 JUN 11 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on Cancer are presented in a new report. According to news reporting originating [...]

Published
2024

42. Pfizer Inc. Files SEC Form 8-K, Current Report: (May 22, 2024)

Subjects
United States. Securities and Exchange Commission -- Reports, Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 JUN 3 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities [...]

Published
2024

43. US Digital Marketing Trends in Non-small Cell Lung Cancer: Merck's Keytruda.com Achieved the Highest Total Traffic Across NSCLC Patient Websites

Subjects
Merck & Company Inc. -- Reports, Pfizer Inc. -- Reports, AstraZeneca PLC -- Reports, Lung cancer, Small cell -- Reports, Lung cancer, Non-small cell -- Reports, Web sites -- Reports, Pharmaceutical industry -- Reports, Search engine optimization -- Reports, Company Web site/Web page, Business, Business, international, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports
Abstract

M2 PRESSWIRE-March 14, 2024-: US Digital Marketing Trends in Non-small Cell Lung Cancer: Merck's Keytruda.com Achieved the Highest Total Traffic Across NSCLC Patient Websites (C)1994-2024 M2 COMMUNICATIONS RDATE:14032024 The 'Digital [...]

Published
2024

44. US Digital Marketing Trends in Non-small Cell Lung Cancer: Merck's Keytruda.com Achieved the Highest Total Traffic Across NSCLC Patient Websites - ResearchAndMarkets.com

Subjects
Merck & Company Inc. -- Reports, Pfizer Inc. -- Reports, AstraZeneca PLC -- Reports, Lung cancer, Small cell -- Reports, Lung cancer, Non-small cell -- Reports, Web sites -- Reports, Pharmaceutical industry -- Reports, Search engine optimization -- Reports, Company Web site/Web page, Business, Business, international, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports
Abstract

DUBLIN -- The 'Digital Marketing Trends in Non-small Cell Lung Cancer' report has been added to ResearchAndMarkets.com's offering. Merck's Keytruda.com achieved the highest total traffic across non-small cell lung cancer [...]

Published
2024

45. Hemophilia A Pipeline Assessment 2024: FDA Approvals, Drugs, Therapies and Companies by DelveInsight | Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, Pfizer, Sanofi Genzyme, Novo Nordisk

Subjects
Genzyme Corp. -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Business -- Research, Biotechnology industry -- Reports, Drugs -- Reports, Hemophilia -- Reports, Drug approval -- Reports, Blood coagulation factor VIII -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-March 1, 2024-: Hemophilia A Pipeline Assessment 2024: FDA Approvals, Drugs, Therapies and Companies by DelveInsight | Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, Pfizer, Sanofi Genzyme, Novo Nordisk, (C)1994-2024 [...]

Published
2024

46. Comparing Safety, Efficacy of COVID-19 mRNA Vaccines in Older Adults

Author

Meara, Killian

Subjects
Pfizer Inc. -- Reports, Biological products industry -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Pulmonary embolism -- Complications and side effects, Messenger RNA -- Reports, Vaccines -- Complications and side effects, Pharmaceutical industry -- Reports, Business, Pharmaceuticals and cosmetics industries
Abstract

Moderna's COVID-19 mRNA vaccine was associated with a lower risk of pulmonary embolism and other adverse events in older adults when compared to Pfizer's, according to recent data published in [...]

Published
2023

47. Pfizer price target lowered to $41 from $45 at JPMorgan

Subjects
Pfizer Inc. -- Reports, Business, News, opinion and commentary
Abstract

JPMorgan lowered the firm's price target on Pfizer to $41 from $45 and keeps a Neutral rating on the shares ahead of the Q2 report. The analyst is modestly below [...]

Published
2023

48. Abrysvo Demonstrates Continued Efficacy in Older Adults Through Second RSV Season: Pfizer's RSV vaccine has a durable efficacy rate of 80% or more after 2 RSV seasons

Author

Biscaldi, Lauren

Subjects
Pfizer Inc. -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Aged -- Reports, Respiratory tract diseases -- Drug therapy, Vaccines -- Reports, Pharmaceutical industry -- Reports, Business, Pharmaceuticals and cosmetics industries, Abrysvo (Vaccine) -- Reports
Abstract

Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo remains efficacious in preventing RSV-associated lower respiratory tract disease in adults 60 years and older through 2 full RSV seasons, according to topline [...]

Published
2024

49. BioNTech pancreatic cancer vaccine 'shows promise' in small trial, NYT says

Subjects
Pfizer Inc. -- Reports, Clinical trials -- Reports, Cancer vaccines -- Reports, Patient education -- Reports, Pancreatic cancer -- Care and treatment, Business, News, opinion and commentary
Abstract

BioNTech (BNTX) produced personalized vaccines designed to teach patients' immune system to attack pancreatic cancer tumors and the cancer vaccines relied on messenger RNA, like BioNTech's COVID vaccine made with [...]

Published
2023

50. Janus kinase (JAK) Inhibitors Competitive Landscape Report 2024

Subjects
Maxinovel Pharmaceuticals Inc. -- Reports, Pfizer Inc. -- Reports, Business -- Research, Biotechnology industry -- Reports, Mutual fund industry -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-February 23, 2024-: Janus kinase (JAK) Inhibitors Competitive Landscape Report 2024 (C)1994-2024 M2 COMMUNICATIONS RDATE:22022024 DelveInsight's, 'Janus kinase inhibitors Competitive landscape 2024' report provides comprehensive insights about 40+ Janus [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results